Chemoprophylaxis for group B Streptococcus transmission in neonates

Annals of Pharmacotherapy

Volumn 31, Issue 1, 1997, Pages 110-112

  Beri, Rakesh ^a   Lourwood, David L ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MICHAEL REESE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; HUMAN; INFECTION PREVENTION; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN INFECTION; PRACTICE GUIDELINE; PRENATAL CARE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VAGINA FLORA;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; PENICILLINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0031014849     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Edwards MS, Baker CJ. Streptococcus agalactiae (group B streptococcus). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. 4th ed. New York: Livingstone, 1995;1835-45.
2. Report of the Committee on Infectious Disease. Group B streptococcal infections. In: 1994 Red book. Elk Grove Village, IL: American Academy of Pediatrics, 1994:439-42.
3. Thomsen AC, Morup L, Brogaard-Hansen K. Antibiotic elimination of group B streptococci in urine in prevention of preterm labour. Lancet 1987;1:591-3.
4. Group B streptococcal infections in pregnancy. ACOG Tech Bull 1992;170(July):1-5.
5. Towers CV. Group B Streptococcus: the US controversy. Lancet 1995;346:197-8.
6. Pyati SP, Pildes RS, Jacobs NM, Ramamurthy RS, Yeh TF, Raval DS, et al. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N Engl J Med 1983;308:1383-8.
7. Morales WJ, Lim DV, Walsh AF. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. Am J Obstet Gynecol 1986;155:979-83.
8. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
9. Garland SM, Fliegner JR. Group B Streptococcus and neonatal infections: the case of intrapartum chemoprophylaxis. Aust N Z Obstet Gynaecol 1991;31:119-22.
10. Klebanoff MA, Regan JA, Rao AV, Nugent RP, Blackwelder WC, Eschenbach WC, et al. Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol 1995;172:1540-5.
11. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996;45(RR-7):1-24.
12. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73:585-7.
13. Walsh J, Hutchins S. Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines. Pediatr Infect Dis J 1989;8:271-7.
14. Erramouspe J, Lourwood DL. Neonatal group B streptococcal infection prevention. Ann Pharmacother 1994;28:474-5.